Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4362-4370

  Register, Thomas C ^a   Jayo, Manuel J ^a,b   Anthony, Mary S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Pathology Associates International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALCIUM; COLLAGEN TYPE 1; CONJUGATED ESTROGEN; PHYTOESTROGEN; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MASS; BONE MINERAL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIET; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN ACTIVITY; EXTRACTION; FEMALE; LONGITUDINAL STUDY; LUMBAR SPINE; MONKEY; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; SOYBEAN; STATISTICAL SIGNIFICANCE;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE AND BONES; BONE DISEASES, METABOLIC; DENSITOMETRY; DIET; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; MACACA FASCICULARIS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PHYTOESTROGENS; PLANT PREPARATIONS; SOYBEANS;

ANIMALIA; EQUIDAE; GLYCINE MAX; MAMMALIA;

EID: 0141787930     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030493     Document Type: Article

References (46)

1. Writing Group for the PEPI 1996 Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 276:1389-1396
2. Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J 1999 The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Postmenopausal Estrogen Progestin Interventions Trial. J Bone Miner Res 14:1583
3. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH 2002 Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 287:2668-2676
4. Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
5. Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ 2002 Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 11:593.600
6. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605-613
7. Adlercreutz H and Mazur W 1997 Phytoestrogens and western diseases. Ann Med 29:95-120
8. Kurzer MS and Xu X 1997 Dietary phytoestrogens. Annu Rev Nutr 17:353-381
9. Messina MJ 1999 Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 70(Suppl):439S-50S
10. Clarkson TB 2000 Soy phytoestrogens: what will be their role in postmenopausal hormone replacement therapy? Menopause 7:71-75
11. WHO Study Group 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Tech Rep Ser 843:11-23
12. Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, Fujiwara S, Hosoda Y, Melton III LJ 1991 A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 133:801-809
13. Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA, Goldberg J 1997 Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol 146:502-509
14. Davis JW, Ross PD, Nevitt MC, Wasnich RD 1997 Incidence rates of falls among Japanese men and women living in Hawaii. J Clin Epidemiol 50:589-594
15. Davis JW, Nevitt MC, Wasnich RD, Ross PD 1999 A cross-cultural comparison of neuromuscular performance, functional status, and falls between Japanese and white women. J Gerontol A Biol Sci Med Sci 54:M288-M292
16. Chin K, Evans MC, Cornish J, Cundy T, Reid IR 1997 Differences in hip axis and femoral neck length in premenopausal women of Polynesian, Asian and European origin. Osteop int 7:344-347
17. Nakamura T, Turner CH, Yoshikawa T, Slemenda CW, Peacock M, Burr DB, Mizuno Y, Orimo H, Ouchi Y, Johnston Jr CC 1994 Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res 9:1071-1076
18. Melton III LJ 1997 Epidemiology of spinal osteoporosis. Spine 22(24 Suppl): 2S-11S
19. Bachrach LK, Hastie T, Wang MC, Narasimhan B, Marcus R 1999 Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 84:4702-4712
20. Melton III LJ 2000 Who has osteoporosis? A conflict between clinical and public health perspectives. J Bone Miner Res 15:2309-2314
21. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H 2000 Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 11:721-724
22. Somekawa Y, Chiguchi M, Ishibashi T, Wakana K, Aso T 2001 Efficacy of ipriflavone in preventing adverse effects of leuprolide. J Clin Endocrinol Metab 86:3202-3206
23. Mei J, Yeung SSC, Kung AWC 2001 High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86:5217-5221
24. Anthony MS, Anderson JJB, Alekel DL 2002 Association between soy and/or isoflavones and bone: evidence from epidemiologic studies. In: Gilani GS, Anderson JJB, eds. Phytoestrogens and health Champaign, IL: AOCS Press; 331-340
25. Kardinaal AF, Morton MS, Bruggemann-Rotgans IE, van Beresteijn EC 1998 Phyto-oestrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr 52:850-855
26. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R, Strauss BJ 1998 Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1:124-129
27. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman Jr JW 1998 Soy protein and isofiavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68(Suppl):1375S-1379S
28. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T 2000 Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852
29. Gallagher JC, Rafferty K, Haynatzka V, Wilson M 2000 The effect of soy protein on bone metabolism [Abstract]. J Nutr 130:667S
30. Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer MS 2000 Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85:3043-3048
31. Chiechi L, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F, Valerio T, Laselva G, Loizzi P 2002 Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 42:295
32. Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB 1995 Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thromb Vasc Biol 15:2094-2100
33. Register TC, Jayo MJ, Jerome CP 1997 Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys Osteoporos Int 7:348-353
34. Clarkson TB, Anthony MS, Morgan TM 2001 Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 86:41-47
35. NIH, Osteoporosis prevention, diagnosis, and therapy NIH consensus statement 2000 March 27-29; [cited 2003, March, 201; 17(1):1-36. URL-http://odp.od.nih.gov/consensus/cons/111/111_statement.htm
36. Jayo MJ, Rankin SE, Weaver DS, Carlson CS, Clarkson TB 1991 Accuracy and precision of lumbar bone mineral content by dual-energy x-ray absorptiometry in live female monkeys. Calcif Tissue Int 49:438-440
37. Setchell KD, Brown NM, Lydeking-Olsen E 2002 The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132:3577-3584
38. Moribato N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, lentile R, Squadrito F 2002 Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17:1904-1912
39. Cline JM, Anthony M, Mathes S, Clarkson TB 2000 Effects of dietary soy on the uterus and breast of macaques. J Nutr 130:669S
40. Cline JM, Soderqvist G, Register TC, Williams JK, Adams MR, Von Schoultz B 2001 Assessment of hormonally active agents in the reproductive tract of female nonhuman primates. Toxicol Pathol 29:84-90
41. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-70
42. Day JK, Besch-Williford C, McMann TR, Hufford MG, Lubahn DB, MacDonald RS 2001 Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER α KO, mice. Nutr Cancer 39:226-232
43. Jacob DA, Temple JL, Patisaul HB, Young LJ, Rissman EF 2001 Coumestrol antagonizes neuroendocrine actions of estrogen via the estrogen receptor α. Exp Biol Med 226:301-306
44. Jefferson WN, Couse JF, Padilla-Banks E, Korach KS, Newbold RR 2002 Neonatal exposure to genistein induces estrogen receptor (ER)α expression and multioocyte follicles in the maturing mouse ovary: evidence for ERβ-mediated and nonestrogenic actions. Biol Reprod 67:1285-1296
45. -/- mice requires the presence of estrogen receptor-α. Arterioscler Thromb Vasc Biol 22:1859-1864
46. Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY 2001 Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized clinical trial. JAMA 285:1482-148